ImpediMed Limited (IPD.AX)
AUD 0.04
(-10.26%)
AUD 0.04
(-10.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -22.05 Million AUD | -7.6% |
| 2023 | -20.49 Million AUD | -10.41% |
| 2022 | -18.65 Million AUD | 13.41% |
| 2021 | -20.7 Million AUD | 11.45% |
| 2020 | -24.07 Million AUD | 9.96% |
| 2019 | -26.33 Million AUD | 11.9% |
| 2018 | -30.34 Million AUD | 0.56% |
| 2017 | -30.51 Million AUD | -7.83% |
| 2016 | -25.99 Million AUD | -89.07% |
| 2015 | -14.97 Million AUD | -91.07% |
| 2014 | -7.83 Million AUD | 15.2% |
| 2013 | -9.23 Million AUD | 28.33% |
| 2012 | -12.89 Million AUD | 8.86% |
| 2011 | -14.14 Million AUD | -32.63% |
| 2010 | -10.66 Million AUD | 18.3% |
| 2009 | -13.24 Million AUD | -69.29% |
| 2008 | -7.71 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -10.92 Million AUD | 0.0% |
| 2024 FY | - AUD | -6.59% |
| 2024 Q4 | -11.7 Million AUD | 0.0% |
| 2023 Q2 | -10.67 Million AUD | 0.0% |
| 2023 FY | - AUD | -10.41% |
| 2023 Q4 | -9.16 Million AUD | 0.0% |
| 2022 Q4 | -9.76 Million AUD | 0.0% |
| 2022 FY | - AUD | 13.41% |
| 2022 Q2 | -8.44 Million AUD | 0.0% |
| 2021 Q4 | -10.19 Million AUD | 0.0% |
| 2021 Q2 | -11.09 Million AUD | 0.0% |
| 2021 FY | - AUD | 11.45% |
| 2020 Q2 | -13.62 Million AUD | 0.0% |
| 2020 Q4 | -10.25 Million AUD | 0.0% |
| 2020 FY | - AUD | 9.96% |
| 2019 Q4 | -12.87 Million AUD | 0.0% |
| 2019 Q2 | -13.43 Million AUD | 0.0% |
| 2019 FY | - AUD | 11.9% |
| 2018 Q2 | -15.63 Million AUD | 0.0% |
| 2018 FY | - AUD | 0.56% |
| 2018 Q4 | -14.71 Million AUD | 0.0% |
| 2017 FY | - AUD | -7.83% |
| 2017 Q2 | -15.33 Million AUD | 0.0% |
| 2017 Q4 | -15.18 Million AUD | 0.0% |
| 2016 Q4 | -17.15 Million AUD | 0.0% |
| 2016 FY | - AUD | -89.07% |
| 2016 Q2 | -11.14 Million AUD | 0.0% |
| 2015 FY | - AUD | -91.07% |
| 2015 Q2 | -6.19 Million AUD | 0.0% |
| 2015 Q4 | -8.77 Million AUD | 0.0% |
| 2014 Q4 | -4.3 Million AUD | 0.0% |
| 2014 FY | - AUD | 15.2% |
| 2014 Q2 | -3.52 Million AUD | 0.0% |
| 2013 Q2 | -5.16 Million AUD | 0.0% |
| 2013 Q4 | -4.07 Million AUD | 0.0% |
| 2013 FY | - AUD | 28.33% |
| 2012 Q3 | -2.96 Million AUD | 0.0% |
| 2012 FY | - AUD | 8.86% |
| 2012 Q2 | -2.96 Million AUD | 16.49% |
| 2012 Q1 | -3.55 Million AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2011 Q1 | -2.68 Million AUD | 0.0% |
| 2011 Q2 | -3.55 Million AUD | -32.46% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | - AUD | -32.63% |
| 2011 Q3 | -3.55 Million AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -2.68 Million AUD | 0.0% |
| 2010 FY | - AUD | 18.3% |
| 2010 Q2 | -2.68 Million AUD | 18.98% |
| 2010 Q1 | -3.31 Million AUD | 0.0% |
| 2009 Q3 | -3.31 Million AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 Q2 | -3.31 Million AUD | -71.85% |
| 2009 Q1 | -1.92 Million AUD | 0.0% |
| 2009 FY | - AUD | -69.29% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q2 | -1.92 Million AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q3 | -1.92 Million AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 38.861% |
| Adherium Limited | -11.56 Million AUD | -90.679% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -199.603% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -306.583% |
| Anteris Technologies Ltd | -66.9 Million AUD | 67.041% |
| Control Bionics Limited | -5.15 Million AUD | -327.494% |
| CardieX Limited | -6.71 Million AUD | -228.538% |
| Compumedics Limited | 2.78 Million AUD | 890.642% |
| Cochlear Limited | 579.5 Million AUD | 103.805% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -531.507% |
| Cyclopharm Limited | -3.03 Million AUD | -626.581% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -954.462% |
| Nova Eye Medical Limited | -5.97 Million AUD | -268.807% |
| HeraMED Limited | -3.97 Million AUD | -455.152% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | -0.826% |
| InhaleRx Limited | -1.41 Million AUD | -1459.76% |
| LBT Innovations Limited | -4.04 Million AUD | -444.604% |
| Micro-X Limited | -14.35 Million AUD | -53.655% |
| Neurotech International Limited | -8.24 Million AUD | -167.478% |
| OncoSil Medical Limited | -11.97 Million AUD | -84.124% |
| PolyNovo Limited | 5.17 Million AUD | 526.518% |
| Respiri Limited | -7.04 Million AUD | -212.784% |
| SomnoMed Limited | -2.32 Million AUD | -846.959% |
| Universal Biosensors, Inc. | -9.09 Million AUD | -142.574% |
| Uscom Limited | -1.5 Million AUD | -1360.999% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -348.429% |